Generics - Regulation

Filter

Current filters:

Regulation

Popular Filters

3313 to 3337 of 3386 results

Pfizer and Bristol-Myers get first approval for blood thinner Eliquis, in EU

23-05-2011

Following a positive recommendation from its drug advisory body (The Pharma Letter March 21), the European…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalRegulation

European Commission clears proposed DSM and Sinochem joint venture

23-05-2011

The European Commission has cleared under the EU Merger Regulation the proposed joint venture between…

Antibiotics and Infectious diseasesAsia-PacificDSMGenericsMergers & AcquisitionsSinochem

Controversial NSAID nimesulide now banned in China for children below 12

23-05-2011

The Chinese regulator, the State Food and Drug Administration (SFDA) has issued a notice banning the…

Asia-PacificDuxilHelsinnNeurologicalnimesulideRegulationServier

Fight over user fees underscores bigger questions about US FDA's mission, Burrill report finds

23-05-2011

Industry frustration is growing over a failure to adequately fund the US Food and Drug Administration…

FinancialNorth AmericaPharmaceuticalRegulation

GlaxoSmithKline’s diabetes drug Avandia to be restricted on US market

20-05-2011

As part of a US Food and Drug Administration re-assessment of UK drug giant GlaxoSmithKline’s troubled…

AvandiaDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Sandoz files for generic of Shire’s Vyvanse; FDA warning

20-05-2011

Ireland-headquartered biopharmaceutical company Shire (LSE: SHP) yesterday revealed that its US subsidiary…

GenericsMarkets & MarketingNeurologicalNorth AmericaNovartisPatentsPharmaceuticalRegulationSandozShireVyvanse

Pharma distribution in Central Europe in 2011: liberalization of non-pharmacy and on-line sales

20-05-2011

Pharmaceutical distribution has been liberalized further in Central Europe in 2011, with Bulgaria making…

EuropeMarkets & MarketingPharmaceuticalRegulation

FDA advisory panel backs continued use of Abbott’s Trilipix with statins

20-05-2011

The US Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee to review…

Abbott LaboratoriesCardio-vascularNorth AmericaPharmaceuticalRegulationTrilipix

Global pharma market will see just 3%-6% growth over next five years, reaching $1,100 billion in 2015

19-05-2011

Global spending for medicines will reach nearly $1,100 billion by 2015, reflecting a slowing compound…

GenericsGlobalMarkets & MarketingPatentsPharmaceutical

Public Citizen says US FDA should immediately pull Eisai and Pfizer’s high-dose Aricept from market

19-05-2011

US consumer watchdog Public Citizen has called for higher doses of Aricept (donepezil), marketed by originator…

AriceptEisaiNeurologicalNorth AmericaPfizerPharmaceuticalRegulation

Eisai gets Swiss approval for Halaven

19-05-2011

Japanese drug major Eisai (TYO: 4532), says that its Halaven(eribulin) has been approved for use in…

EisaiEuropeHalavenOncologyPharmaceuticalRegulation

Pfizer files for US and Japanese approval of crizotinib for NSCLC

18-05-2011

US drug behemoth Pfizer (NYSE: PFE) says that its New Drug Application for crizotinib, an oral first-in-class…

Asia-PacificcrizotinibNorth AmericaOncologyPfizerPharmaceuticalRegulation

Israeli generics giant Teva wins largest share of German health insurance AOK tenders

18-05-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s biggest generic drugmaker,…

EuropeGenericsMarkets & MarketingTeva Pharmaceutical Industries

Australia’s TGA approves Biogen’s Fampyra to improve MS patients walking ability

18-05-2011

The Australian Therapeutic Goods Administration (TGA) has granted approval for USA-based Biogen Idec’s…

AmpyraAsia-PacificBiogen IdecFampyraNeurologicalPharmaceuticalRegulation

Alimera resubmits eye drug Iluvien to US regulator

17-05-2011

USA-based Alimera Sciences (Nasdaq: ALIM) says that it has resubmitted its New Drug Application for Iluvien…

Alimera SciencesIluvienNorth AmericaOphthalmicsPharmaceuticalpSividaRegulation

US FDA clears first hep C drug in a decade, Merck & Co’s Victrelis

16-05-2011

In much awaited, though largely expected news, the US Food and Drug Administration on Friday approved…

Anti-viralsboceprevirMerck & CoNorth AmericaPharmaceuticalRegulationtelaprevirVertexVictrelis

US Medicare likely to run out of funds in 2024; Congressional Affordable Medicines Caucus

16-05-2011

The US Trustees of the Social Security and Medicare trust funds report on the current and projected financial…

GenericsHealthcareNorth AmericaPharmaceuticalPoliticsPricing

Dr Reddy’s launches Neulastim copy in India; doubles 4th-qtr profit

16-05-2011

Hyderabad, India-based generic drugmaker Dr Reddy’s Laboratories (NYSE: RDY) has launched its Peg-grafeel,…

Asia-PacificDr Reddy's LaboratoriesFinancialGenericsMarkets & MarketingNeulastimOncologyPeg-grafeelRoche

Australia clears way for increased access to generic medicines

13-05-2011

Australian consumers and health professionals will have more ready access to generic medicines following…

Asia-PacificGenericsHealthcarePatents

Merck & Co debuts Simponi in the UK for RA, PsA and AS

13-05-2011

US drug giant Merck & Co (NYSE: MRK), through its subsidiary MSD, yesterday announced the UK availability…

Anti-Arthritics/RheumaticsEuropeMarkets & MarketingMerck & CoPharmaceuticalRegulationSimponi Injection

3313 to 3337 of 3386 results

Back to top